SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-036936
Filing Date
2012-05-14
Accepted
2012-05-14 16:21:47
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-8811_110q.htm 10-Q 645503
2 EX-31.1 a12-8811_1ex31d1.htm EX-31.1 10356
3 EX-31.2 a12-8811_1ex31d2.htm EX-31.2 10438
4 EX-32.1 a12-8811_1ex32d1.htm EX-32.1 8728
  Complete submission text file 0001104659-12-036936.txt   2692522

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hlcs-20120331.xml EX-101.INS 188587
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hlcs-20120331.xsd EX-101.SCH 32388
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hlcs-20120331_cal.xml EX-101.CAL 80481
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hlcs-20120331_lab.xml EX-101.LAB 438852
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hlcs-20120331_pre.xml EX-101.PRE 176639
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hlcs-20120331_def.xml EX-101.DEF 127440
Mailing Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139 617-649-0540
HELICOS BIOSCIENCES CORP (Filer) CIK: 0001274563 (see all company filings)

IRS No.: 050587367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33484 | Film No.: 12838973
SIC: 2834 Pharmaceutical Preparations